Theralase Technologies Inc. (TLT.V)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.59 Million CAD | 11.66% |
| 2022 | -5.2 Million CAD | -15.09% |
| 2021 | -4.51 Million CAD | 19.2% |
| 2020 | -5.59 Million CAD | 24.28% |
| 2019 | -7.38 Million CAD | -119.36% |
| 2018 | -3.36 Million CAD | 44.66% |
| 2017 | -6.08 Million CAD | -223.64% |
| 2016 | 4.92 Million CAD | -5.51% |
| 2015 | 5.2 Million CAD | 102.15% |
| 2014 | 2.57 Million CAD | 133.41% |
| 2013 | 1.1 Million CAD | -26.88% |
| 2012 | 1.5 Million CAD | 203.35% |
| 2011 | -1.46 Million CAD | -221.4% |
| 2010 | 1.2 Million CAD | 397.51% |
| 2009 | 241.82 Thousand CAD | -78.24% |
| 2008 | 1.11 Million CAD | 1.53% |
| 2007 | 1.09 Million CAD | 280.14% |
| 2006 | 287.89 Thousand CAD | 2299.51% |
| 2005 | 11.99 Thousand CAD | -80.57% |
| 2004 | 61.74 Thousand CAD | 15.01% |
| 2003 | 53.68 Thousand CAD | 8.09% |
| 2002 | 49.66 Thousand CAD | -90.17% |
| 2001 | 505.17 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.46 Million CAD | -46.02% |
| 2024 Q2 | -1.13 Million CAD | 22.0% |
| 2023 Q2 | -1.16 Million CAD | 17.21% |
| 2023 Q3 | -1 Million CAD | 13.59% |
| 2023 Q4 | -1 Million CAD | 0.23% |
| 2023 FY | -4.59 Million CAD | 11.66% |
| 2023 Q1 | -1.4 Million CAD | -60.87% |
| 2022 Q1 | -1.7 Million CAD | -33.4% |
| 2022 Q2 | -1.24 Million CAD | 27.39% |
| 2022 Q3 | -1.38 Million CAD | -11.33% |
| 2022 FY | -5.2 Million CAD | -15.09% |
| 2022 Q4 | -871.78 Thousand CAD | 36.86% |
| 2021 Q1 | -1.05 Million CAD | -17.81% |
| 2021 Q2 | -1.14 Million CAD | -8.23% |
| 2021 Q3 | -1.07 Million CAD | 5.54% |
| 2021 Q4 | -1.28 Million CAD | -18.9% |
| 2021 FY | -4.51 Million CAD | 19.2% |
| 2020 Q4 | -894.22 Thousand CAD | 38.37% |
| 2020 Q3 | -1.45 Million CAD | 11.86% |
| 2020 Q2 | -1.64 Million CAD | 3.48% |
| 2020 Q1 | -1.7 Million CAD | 43.63% |
| 2020 FY | -5.59 Million CAD | 24.28% |
| 2019 Q3 | -1.78 Million CAD | -20.3% |
| 2019 FY | -7.38 Million CAD | -119.36% |
| 2019 Q1 | -1.12 Million CAD | -51.04% |
| 2019 Q2 | -1.48 Million CAD | -32.29% |
| 2019 Q4 | -3.02 Million CAD | -69.24% |
| 2018 Q3 | -729.39 Thousand CAD | 18.19% |
| 2018 FY | -3.36 Million CAD | 44.66% |
| 2018 Q4 | -743.7 Thousand CAD | -1.96% |
| 2018 Q1 | -1 Million CAD | 16.86% |
| 2018 Q2 | -891.55 Thousand CAD | 11.07% |
| 2017 Q4 | -1.2 Million CAD | -172.83% |
| 2017 Q3 | 1.65 Million CAD | -6.23% |
| 2017 Q2 | 1.76 Million CAD | 19.95% |
| 2017 Q1 | 1.47 Million CAD | 46.79% |
| 2017 FY | -6.08 Million CAD | -223.64% |
| 2016 Q1 | 1.14 Million CAD | 19.96% |
| 2016 Q3 | 1.46 Million CAD | 17.48% |
| 2016 Q4 | 1 Million CAD | -31.4% |
| 2016 FY | 4.92 Million CAD | -5.51% |
| 2016 Q2 | 1.24 Million CAD | 8.61% |
| 2015 Q1 | 933.64 Thousand CAD | 11.18% |
| 2015 FY | 5.2 Million CAD | 102.15% |
| 2015 Q4 | 955.06 Thousand CAD | -51.62% |
| 2015 Q3 | 1.97 Million CAD | 46.71% |
| 2015 Q2 | 1.34 Million CAD | 44.11% |
| 2014 Q2 | 358.93 Thousand CAD | 11.88% |
| 2014 FY | 2.57 Million CAD | 133.41% |
| 2014 Q1 | 320.81 Thousand CAD | -36.72% |
| 2014 Q3 | -1.05 Million CAD | -394.47% |
| 2014 Q4 | 839.76 Thousand CAD | 179.45% |
| 2013 Q1 | 332.43 Thousand CAD | -36.59% |
| 2013 FY | 1.1 Million CAD | -26.88% |
| 2013 Q4 | 506.97 Thousand CAD | 172.87% |
| 2013 Q3 | 185.79 Thousand CAD | 170.45% |
| 2013 Q2 | 68.69 Thousand CAD | -79.33% |
| 2012 Q4 | 524.27 Thousand CAD | 51.42% |
| 2012 Q3 | 346.23 Thousand CAD | 77.23% |
| 2012 Q2 | 195.35 Thousand CAD | 143.35% |
| 2012 Q1 | -450.67 Thousand CAD | -99.61% |
| 2012 FY | 1.5 Million CAD | 203.35% |
| 2011 FY | -1.46 Million CAD | -221.4% |
| 2011 Q4 | -225.78 Thousand CAD | -153.01% |
| 2011 Q1 | 449.08 Thousand CAD | 38.71% |
| 2011 Q2 | 359.8 Thousand CAD | -19.88% |
| 2011 Q3 | 425.94 Thousand CAD | 18.38% |
| 2010 Q3 | 402.86 Thousand CAD | 102.19% |
| 2010 Q4 | 323.76 Thousand CAD | -19.64% |
| 2010 Q2 | 199.24 Thousand CAD | -28.13% |
| 2010 FY | 1.2 Million CAD | 397.51% |
| 2010 Q1 | 277.24 Thousand CAD | 413.39% |
| 2009 Q1 | 216.25 Thousand CAD | -29.14% |
| 2009 Q2 | 26.16 Thousand CAD | -87.9% |
| 2009 Q4 | -88.46 Thousand CAD | -200.68% |
| 2009 Q3 | 87.87 Thousand CAD | 235.84% |
| 2009 FY | 241.82 Thousand CAD | -78.24% |
| 2008 Q1 | 346.93 Thousand CAD | -52.51% |
| 2008 Q4 | 305.17 Thousand CAD | 28.15% |
| 2008 Q3 | 238.13 Thousand CAD | 7.78% |
| 2008 Q2 | 220.93 Thousand CAD | -36.32% |
| 2008 FY | 1.11 Million CAD | 1.53% |
| 2007 Q4 | 730.47 Thousand CAD | 274.2% |
| 2007 FY | 1.09 Million CAD | 280.14% |
| 2007 Q1 | -76.17 Thousand CAD | -148.71% |
| 2007 Q2 | 92.53 Thousand CAD | 221.47% |
| 2007 Q3 | 195.21 Thousand CAD | 110.96% |
| 2006 Q2 | 54.26 Thousand CAD | -26.65% |
| 2006 FY | 287.89 Thousand CAD | 2299.51% |
| 2006 Q4 | 156.37 Thousand CAD | 4673.38% |
| 2006 Q1 | 73.97 Thousand CAD | 553.98% |
| 2006 Q3 | 3276.00 CAD | -93.96% |
| 2005 FY | 11.99 Thousand CAD | -80.57% |
| 2005 Q2 | 40.54 Thousand CAD | 459.79% |
| 2005 Q3 | -5005.00 CAD | -112.35% |
| 2005 Q4 | -16.29 Thousand CAD | -225.57% |
| 2005 Q1 | 7242.00 CAD | 294.83% |
| 2004 Q3 | -16.09 Thousand CAD | -133.98% |
| 2004 Q2 | 47.38 Thousand CAD | 2206.77% |
| 2004 FY | 61.74 Thousand CAD | 15.01% |
| 2004 Q4 | -3717.00 CAD | 76.91% |
| 2004 Q1 | 2054.00 CAD | -85.49% |
| 2003 Q2 | -11.01 Thousand CAD | 11.45% |
| 2003 Q1 | -12.43 Thousand CAD | -207.19% |
| 2003 FY | 53.68 Thousand CAD | 8.09% |
| 2003 Q4 | 14.15 Thousand CAD | -11.97% |
| 2003 Q3 | 16.07 Thousand CAD | 245.96% |
| 2002 Q1 | 11.79 Thousand CAD | 0.0% |
| 2002 Q4 | 11.6 Thousand CAD | -27.28% |
| 2002 FY | 49.66 Thousand CAD | -90.17% |
| 2002 Q3 | 15.95 Thousand CAD | 39.43% |
| 2002 Q2 | 11.44 Thousand CAD | -2.98% |
| 2001 FY | 505.17 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -20.72 Million CAD | 77.837% |
| Therma Bright Inc. | -3.6 Million CAD | -27.507% |
| VentriPoint Diagnostics Ltd. | -4.93 Million CAD | 6.819% |